» Articles » PMID: 38674007

The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38674007
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of two major types of skin cancer, melanoma and non-melanoma skin cancer, has been increasing worldwide. Skin cancer incidence is estimated to rise continuously over the next 20 years due to ozone depletion and an increased life expectancy. Chemotherapeutic agents could affect healthy cells, and thus may be toxic to them and cause numerous side effects or drug resistance. Phytochemicals that are naturally occurring in fruits, plants, and herbs are known to possess various bioactive properties, including anticancer properties. Although the effects of phytochemicals are relatively milder than chemotherapeutic agents, the long-term intake of phytochemicals may be effective and safe in preventing tumor development in humans. Diverse phytochemicals have shown anti-tumorigenic activities for either melanoma or non-melanoma skin cancer. In this review, we focused on summarizing recent research findings of the natural and dietary terpenoids (eucalyptol, eugenol, geraniol, linalool, and ursolic acid) that have anticancer activities for both melanoma and non-melanoma skin cancers. These terpenoids may be helpful to protect skin collectively to prevent tumorigenesis of both melanoma and nonmelanoma skin cancers.

Citing Articles

Gossypin-Loaded Ethosome Gel for Cutaneous Administration: A Preliminary Study on Melanoma Cells.

Bondi A, Pula W, Benedusi M, Trinchera G, Baldisserotto A, Manfredini S Antioxidants (Basel). 2025; 14(2).

PMID: 40002373 PMC: 11852004. DOI: 10.3390/antiox14020186.


Alchemy in Nature: The Role of Extract Choice in Crafting Potent Anticancer Metal Nanoparticles.

El-Fitiany R, El Nahas R, Al Balkhi S, Aljaeedi S, Alblooshi A, Hassan F ACS Appl Mater Interfaces. 2025; 17(3):4637-4661.

PMID: 39798120 PMC: 11759054. DOI: 10.1021/acsami.4c19585.


Biocompatible Naringin loaded low molecular peptide Nanogels are effective against human melanoma cells.

Secerli J, Karayavuz B, Aksoy R, Erdogan H, Gudul Bacanli M Toxicol Res (Camb). 2024; 13(6):tfae185.

PMID: 39524611 PMC: 11542622. DOI: 10.1093/toxres/tfae185.


Preparation of Composite Hydrogels Based on Cysteine-Silver Sol and Methylene Blue as Promising Systems for Anticancer Photodynamic Therapy.

Vishnevetskii D, Metlin F, Andrianova Y, Polyakova E, Ivanova A, Averkin D Gels. 2024; 10(9).

PMID: 39330179 PMC: 11431599. DOI: 10.3390/gels10090577.

References
1.
Attwooll C, Denchi E, Helin K . The E2F family: specific functions and overlapping interests. EMBO J. 2004; 23(24):4709-16. PMC: 535093. DOI: 10.1038/sj.emboj.7600481. View

2.
Crespo-Ortiz M, Wei M . Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2011; 2012:247597. PMC: 3228295. DOI: 10.1155/2012/247597. View

3.
Lee W, Lockniskar M, Fischer S . Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J. 1994; 8(13):1081-7. View

4.
Satter E, Metcalf J, Lountzis N, Elston D . Tumors composed of malignant epithelial and melanocytic populations: a case series and review of the literature. J Cutan Pathol. 2008; 36(2):211-9. DOI: 10.1111/j.1600-0560.2008.01000.x. View

5.
Wroblewska-Luczka P, Cabaj J, Bargiel J, Luszczki J . Anticancer effect of terpenes: focus on malignant melanoma. Pharmacol Rep. 2023; 75(5):1115-1125. PMC: 10539410. DOI: 10.1007/s43440-023-00512-1. View